nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—Urinary hesitation—Propantheline—pancreatitis	0.0704	0.0831	CcSEcCtD
Levomilnacipran—Angle closure glaucoma—Hyoscyamine—pancreatitis	0.0549	0.0648	CcSEcCtD
Levomilnacipran—Accommodation disorder—Propantheline—pancreatitis	0.0503	0.0594	CcSEcCtD
Levomilnacipran—Urinary hesitation—Hyoscyamine—pancreatitis	0.036	0.0425	CcSEcCtD
Levomilnacipran—Accommodation disorder—Hyoscyamine—pancreatitis	0.0257	0.0304	CcSEcCtD
Levomilnacipran—Supraventricular tachycardia—Hyoscyamine—pancreatitis	0.0226	0.0266	CcSEcCtD
Levomilnacipran—Thirst—Propantheline—pancreatitis	0.022	0.026	CcSEcCtD
Levomilnacipran—Mania—Hyoscyamine—pancreatitis	0.0203	0.024	CcSEcCtD
Levomilnacipran—Abdominal distension—Propantheline—pancreatitis	0.0182	0.0215	CcSEcCtD
Levomilnacipran—Delirium—Hyoscyamine—pancreatitis	0.0172	0.0203	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Propantheline—pancreatitis	0.0167	0.0197	CcSEcCtD
Levomilnacipran—Gastrooesophageal reflux disease—Hyoscyamine—pancreatitis	0.0164	0.0193	CcSEcCtD
Levomilnacipran—Ventricular extrasystoles—Hyoscyamine—pancreatitis	0.0164	0.0193	CcSEcCtD
Levomilnacipran—Blood pressure increased—Hyoscyamine—pancreatitis	0.0148	0.0175	CcSEcCtD
Levomilnacipran—Dry eye—Hyoscyamine—pancreatitis	0.0137	0.0161	CcSEcCtD
Levomilnacipran—Flushing—Propantheline—pancreatitis	0.0135	0.0159	CcSEcCtD
Levomilnacipran—Tension—Propantheline—pancreatitis	0.0124	0.0146	CcSEcCtD
Levomilnacipran—Vision blurred—Propantheline—pancreatitis	0.0119	0.014	CcSEcCtD
Levomilnacipran—Thirst—Hyoscyamine—pancreatitis	0.0113	0.0133	CcSEcCtD
Levomilnacipran—Palpitations—Propantheline—pancreatitis	0.0112	0.0132	CcSEcCtD
Levomilnacipran—Hyponatraemia—Hyoscyamine—pancreatitis	0.0108	0.0127	CcSEcCtD
Levomilnacipran—Dry mouth—Propantheline—pancreatitis	0.0105	0.0124	CcSEcCtD
Levomilnacipran—Irritability—Hyoscyamine—pancreatitis	0.0102	0.0121	CcSEcCtD
Levomilnacipran—Urinary retention—Hyoscyamine—pancreatitis	0.0102	0.012	CcSEcCtD
Levomilnacipran—Tachycardia—Propantheline—pancreatitis	0.0101	0.0119	CcSEcCtD
Levomilnacipran—Dry skin—Hyoscyamine—pancreatitis	0.00984	0.0116	CcSEcCtD
Levomilnacipran—Abdominal distension—Hyoscyamine—pancreatitis	0.00934	0.011	CcSEcCtD
Levomilnacipran—Insomnia—Propantheline—pancreatitis	0.00932	0.011	CcSEcCtD
Levomilnacipran—Somnolence—Propantheline—pancreatitis	0.00916	0.0108	CcSEcCtD
Levomilnacipran—Angina pectoris—Hyoscyamine—pancreatitis	0.00904	0.0107	CcSEcCtD
Levomilnacipran—Constipation—Propantheline—pancreatitis	0.00881	0.0104	CcSEcCtD
Levomilnacipran—Dysuria—Hyoscyamine—pancreatitis	0.00867	0.0102	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00854	0.0101	CcSEcCtD
Levomilnacipran—Urticaria—Propantheline—pancreatitis	0.00819	0.00966	CcSEcCtD
Levomilnacipran—CYP2J2—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.0081	0.0531	CbGpPWpGaD
Levomilnacipran—Hypersensitivity—Propantheline—pancreatitis	0.00759	0.00896	CcSEcCtD
Levomilnacipran—Asthenia—Propantheline—pancreatitis	0.00739	0.00873	CcSEcCtD
Levomilnacipran—Hallucination—Hyoscyamine—pancreatitis	0.00739	0.00872	CcSEcCtD
Levomilnacipran—Flushing—Hyoscyamine—pancreatitis	0.00689	0.00813	CcSEcCtD
Levomilnacipran—Dizziness—Propantheline—pancreatitis	0.00681	0.00804	CcSEcCtD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.00657	0.043	CbGpPWpGaD
Levomilnacipran—Vomiting—Propantheline—pancreatitis	0.00655	0.00773	CcSEcCtD
Levomilnacipran—Mental disorder—Hyoscyamine—pancreatitis	0.00651	0.00768	CcSEcCtD
Levomilnacipran—Rash—Propantheline—pancreatitis	0.0065	0.00767	CcSEcCtD
Levomilnacipran—Dermatitis—Propantheline—pancreatitis	0.00649	0.00766	CcSEcCtD
Levomilnacipran—Headache—Propantheline—pancreatitis	0.00646	0.00762	CcSEcCtD
Levomilnacipran—Tension—Hyoscyamine—pancreatitis	0.00634	0.00749	CcSEcCtD
Levomilnacipran—Dysgeusia—Hyoscyamine—pancreatitis	0.00633	0.00747	CcSEcCtD
Levomilnacipran—Nausea—Propantheline—pancreatitis	0.00612	0.00722	CcSEcCtD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.0061	0.04	CbGpPWpGaD
Levomilnacipran—Vision blurred—Hyoscyamine—pancreatitis	0.00609	0.00719	CcSEcCtD
Levomilnacipran—Agitation—Hyoscyamine—pancreatitis	0.00594	0.00701	CcSEcCtD
Levomilnacipran—Syncope—Hyoscyamine—pancreatitis	0.0058	0.00684	CcSEcCtD
Levomilnacipran—Palpitations—Hyoscyamine—pancreatitis	0.00571	0.00674	CcSEcCtD
Levomilnacipran—Loss of consciousness—Hyoscyamine—pancreatitis	0.00568	0.0067	CcSEcCtD
Levomilnacipran—Convulsion—Hyoscyamine—pancreatitis	0.0056	0.00661	CcSEcCtD
Levomilnacipran—Chest pain—Hyoscyamine—pancreatitis	0.0055	0.00649	CcSEcCtD
Levomilnacipran—Anxiety—Hyoscyamine—pancreatitis	0.00548	0.00647	CcSEcCtD
Levomilnacipran—Dry mouth—Hyoscyamine—pancreatitis	0.00538	0.00635	CcSEcCtD
Levomilnacipran—Shock—Hyoscyamine—pancreatitis	0.00519	0.00613	CcSEcCtD
Levomilnacipran—Tachycardia—Hyoscyamine—pancreatitis	0.00515	0.00608	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Hyoscyamine—pancreatitis	0.0051	0.00602	CcSEcCtD
Levomilnacipran—Hypotension—Hyoscyamine—pancreatitis	0.00493	0.00582	CcSEcCtD
Levomilnacipran—CYP2J2—Tryptophan metabolism—ALDH2—pancreatitis	0.00489	0.032	CbGpPWpGaD
Levomilnacipran—Insomnia—Hyoscyamine—pancreatitis	0.00477	0.00563	CcSEcCtD
Levomilnacipran—Dyspnoea—Hyoscyamine—pancreatitis	0.0047	0.00555	CcSEcCtD
Levomilnacipran—Somnolence—Hyoscyamine—pancreatitis	0.00469	0.00553	CcSEcCtD
Levomilnacipran—Dyspepsia—Hyoscyamine—pancreatitis	0.00464	0.00548	CcSEcCtD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.00455	0.0298	CbGpPWpGaD
Levomilnacipran—Fatigue—Hyoscyamine—pancreatitis	0.00455	0.00537	CcSEcCtD
Levomilnacipran—Constipation—Hyoscyamine—pancreatitis	0.00451	0.00532	CcSEcCtD
Levomilnacipran—CYP2D6—Fatty Acid Omega Oxidation—ADH4—pancreatitis	0.00444	0.0291	CbGpPWpGaD
Levomilnacipran—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00431	0.00509	CcSEcCtD
Levomilnacipran—Urticaria—Hyoscyamine—pancreatitis	0.00419	0.00495	CcSEcCtD
Levomilnacipran—Body temperature increased—Hyoscyamine—pancreatitis	0.00417	0.00492	CcSEcCtD
Levomilnacipran—Abdominal pain—Hyoscyamine—pancreatitis	0.00417	0.00492	CcSEcCtD
Levomilnacipran—Hypersensitivity—Hyoscyamine—pancreatitis	0.00389	0.00459	CcSEcCtD
Levomilnacipran—Asthenia—Hyoscyamine—pancreatitis	0.00379	0.00447	CcSEcCtD
Levomilnacipran—Pruritus—Hyoscyamine—pancreatitis	0.00373	0.0044	CcSEcCtD
Levomilnacipran—Diarrhoea—Hyoscyamine—pancreatitis	0.00361	0.00426	CcSEcCtD
Levomilnacipran—Dizziness—Hyoscyamine—pancreatitis	0.00349	0.00412	CcSEcCtD
Levomilnacipran—CYP2J2—Biological oxidations—FDX1—pancreatitis	0.00349	0.0228	CbGpPWpGaD
Levomilnacipran—Vomiting—Hyoscyamine—pancreatitis	0.00335	0.00396	CcSEcCtD
Levomilnacipran—Rash—Hyoscyamine—pancreatitis	0.00333	0.00393	CcSEcCtD
Levomilnacipran—Dermatitis—Hyoscyamine—pancreatitis	0.00332	0.00392	CcSEcCtD
Levomilnacipran—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pancreatitis	0.00331	0.0217	CbGpPWpGaD
Levomilnacipran—Headache—Hyoscyamine—pancreatitis	0.0033	0.0039	CcSEcCtD
Levomilnacipran—CYP2J2—Biological oxidations—ADH4—pancreatitis	0.00324	0.0212	CbGpPWpGaD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.00321	0.021	CbGpPWpGaD
Levomilnacipran—Nausea—Hyoscyamine—pancreatitis	0.00313	0.0037	CcSEcCtD
Levomilnacipran—CYP3A4—Fatty Acid Omega Oxidation—ADH4—pancreatitis	0.0029	0.019	CbGpPWpGaD
Levomilnacipran—ABCB1—ABC-family proteins mediated transport—CFTR—pancreatitis	0.0029	0.019	CbGpPWpGaD
Levomilnacipran—SLC6A4—Serotonin Transporter Activity—IL1B—pancreatitis	0.0028	0.0184	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—ADH1B—pancreatitis	0.00242	0.0158	CbGpPWpGaD
Levomilnacipran—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—pancreatitis	0.00233	0.0153	CbGpPWpGaD
Levomilnacipran—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pancreatitis	0.00217	0.0142	CbGpPWpGaD
Levomilnacipran—CYP2C8—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.00202	0.0132	CbGpPWpGaD
Levomilnacipran—CYP2C19—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.0018	0.0118	CbGpPWpGaD
Levomilnacipran—CYP2J2—Tryptophan metabolism—MDM2—pancreatitis	0.00173	0.0114	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—ALDH2—pancreatitis	0.0017	0.0112	CbGpPWpGaD
Levomilnacipran—CYP2D6—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.00166	0.0109	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.00164	0.0107	CbGpPWpGaD
Levomilnacipran—CYP2J2—Arachidonic acid metabolism—PTGS2—pancreatitis	0.00156	0.0102	CbGpPWpGaD
Levomilnacipran—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—pancreatitis	0.00153	0.00999	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.00152	0.00998	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.00146	0.00958	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.00136	0.00891	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.00135	0.00881	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	0.00134	0.00877	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—HSP90AB1—pancreatitis	0.00134	0.00877	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.00125	0.00819	CbGpPWpGaD
Levomilnacipran—SLC6A4—Monoamine Transport—IL1B—pancreatitis	0.00119	0.00782	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—TACR1—pancreatitis	0.00116	0.00758	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—HSP90AB1—pancreatitis	0.00115	0.00754	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—SERPINA1—pancreatitis	0.00115	0.00751	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.00114	0.00744	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	0.00111	0.00727	CbGpPWpGaD
Levomilnacipran—CYP3A4—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.00109	0.00711	CbGpPWpGaD
Levomilnacipran—SLC6A2—Monoamine Transport—IL1B—pancreatitis	0.00103	0.00672	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL13—pancreatitis	0.00102	0.00671	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.00101	0.00664	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—SERPINA1—pancreatitis	0.000986	0.00646	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—MTNR1B—pancreatitis	0.000969	0.00635	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.000933	0.00611	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—SST—pancreatitis	0.000899	0.00589	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.00088	0.00576	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—FDX1—pancreatitis	0.000871	0.0057	CbGpPWpGaD
Levomilnacipran—SLC6A4—Monoamine Transport—TNF—pancreatitis	0.000866	0.00567	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—EGR1—pancreatitis	0.000819	0.00536	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.000818	0.00536	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—ADH4—pancreatitis	0.000809	0.0053	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.0008	0.00524	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—FDX1—pancreatitis	0.000777	0.00509	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—EGR1—pancreatitis	0.000776	0.00509	CbGpPWpGaD
Levomilnacipran—SLC6A2—Monoamine Transport—TNF—pancreatitis	0.000745	0.00488	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	0.00074	0.00485	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—ADH4—pancreatitis	0.000722	0.00473	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—A2M—pancreatitis	0.000715	0.00468	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—FDX1—pancreatitis	0.000715	0.00468	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.000714	0.00468	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—EGR1—pancreatitis	0.000704	0.00461	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CTRB2—pancreatitis	0.000688	0.00451	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—CFTR—pancreatitis	0.000688	0.0045	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—HGF—pancreatitis	0.000676	0.00443	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL13—pancreatitis	0.000669	0.00438	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—ADH4—pancreatitis	0.000665	0.00435	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.000657	0.0043	CbGpPWpGaD
Levomilnacipran—CYP3A4—Tryptophan metabolism—ALDH2—pancreatitis	0.000656	0.00429	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—pancreatitis	0.000648	0.00425	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL10—pancreatitis	0.000641	0.0042	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—EGR1—pancreatitis	0.000634	0.00415	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.00061	0.00399	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—ADH1B—pancreatitis	0.000604	0.00395	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—FDX1—pancreatitis	0.000596	0.00391	CbGpPWpGaD
Levomilnacipran—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.000588	0.00385	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—HGF—pancreatitis	0.000581	0.00381	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—HTR2A—pancreatitis	0.000567	0.00372	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ADH4—pancreatitis	0.000554	0.00363	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—ADH1B—pancreatitis	0.000539	0.00353	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PRSS1—pancreatitis	0.000521	0.00342	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—ADH1B—pancreatitis	0.000495	0.00325	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PNLIP—pancreatitis	0.000494	0.00324	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PRSS3—pancreatitis	0.000494	0.00324	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—HLA-DQA1—pancreatitis	0.000473	0.0031	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—FDX1—pancreatitis	0.000467	0.00306	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—XDH—pancreatitis	0.000443	0.0029	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—ADH4—pancreatitis	0.000434	0.00285	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—LEP—pancreatitis	0.00043	0.00282	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.00043	0.00281	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—ALDH2—pancreatitis	0.000425	0.00279	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL10—pancreatitis	0.000418	0.00274	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ADH1B—pancreatitis	0.000413	0.00271	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—HSP90AB1—pancreatitis	0.000409	0.00268	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—TRPV1—pancreatitis	0.000405	0.00265	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—LEP—pancreatitis	0.000397	0.0026	CbGpPWpGaD
Levomilnacipran—CYP2C8—Arachidonic acid metabolism—PTGS2—pancreatitis	0.00039	0.00256	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	0.000389	0.00255	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—ALDH2—pancreatitis	0.00038	0.00249	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—PPARG—pancreatitis	0.000375	0.00246	CbGpPWpGaD
Levomilnacipran—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.000362	0.00237	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—CXCL8—pancreatitis	0.00035	0.0023	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—ALDH2—pancreatitis	0.000349	0.00229	CbGpPWpGaD
Levomilnacipran—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatitis	0.000348	0.00228	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—HLA-DRB1—pancreatitis	0.000337	0.00221	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL1B—pancreatitis	0.000336	0.0022	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—CASP3—pancreatitis	0.000335	0.0022	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	0.000334	0.00219	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PLA2G1B—pancreatitis	0.00033	0.00216	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—ADH1B—pancreatitis	0.000324	0.00212	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—A2M—pancreatitis	0.000318	0.00209	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—pancreatitis	0.000317	0.00207	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—CFTR—pancreatitis	0.000303	0.00198	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	0.000298	0.00195	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ALDH2—pancreatitis	0.000291	0.00191	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	0.000284	0.00186	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	0.000277	0.00181	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—TGFB1—pancreatitis	0.000275	0.0018	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	0.000255	0.00167	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—pancreatitis	0.00025	0.00164	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	0.000247	0.00162	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—TNF—pancreatitis	0.000244	0.0016	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—TGFB1—pancreatitis	0.000237	0.00155	CbGpPWpGaD
Levomilnacipran—SLC6A2—SLC-mediated transmembrane transport—ALB—pancreatitis	0.000236	0.00155	CbGpPWpGaD
Levomilnacipran—CYP3A4—Tryptophan metabolism—MDM2—pancreatitis	0.000232	0.00152	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CXCL8—pancreatitis	0.000229	0.0015	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—ALDH2—pancreatitis	0.000228	0.00149	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—pancreatitis	0.000228	0.00149	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	0.000223	0.00146	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GCG—pancreatitis	0.000221	0.00145	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL1B—pancreatitis	0.000219	0.00144	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CASP3—pancreatitis	0.000219	0.00143	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL6—pancreatitis	0.000197	0.00129	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	0.000185	0.00121	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—A2M—pancreatitis	0.000179	0.00117	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—TRPV1—pancreatitis	0.000178	0.00117	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—LPL—pancreatitis	0.000173	0.00113	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CTRB2—pancreatitis	0.000172	0.00112	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—TGFB1—pancreatitis	0.00017	0.00112	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	0.000165	0.00108	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—IL6—pancreatitis	0.000161	0.00105	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—A2M—pancreatitis	0.000159	0.00104	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—TNF—pancreatitis	0.000159	0.00104	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CTRB2—pancreatitis	0.000153	0.001	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CTRB2—pancreatitis	0.00015	0.00098	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—FDX1—pancreatitis	0.000149	0.000975	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CTRB2—pancreatitis	0.000141	0.000924	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADH4—pancreatitis	0.000138	0.000907	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—FDX1—pancreatitis	0.000133	0.000871	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PRSS1—pancreatitis	0.00013	0.000853	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—FDX1—pancreatitis	0.00013	0.00085	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PPARG—pancreatitis	0.000126	0.000828	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—INS—pancreatitis	0.000124	0.000813	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADH4—pancreatitis	0.000124	0.000809	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PNLIP—pancreatitis	0.000123	0.000808	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PRSS3—pancreatitis	0.000123	0.000808	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—FDX1—pancreatitis	0.000122	0.000801	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	0.000121	0.000791	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADH4—pancreatitis	0.000121	0.00079	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ALB—pancreatitis	0.00012	0.000786	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatitis	0.000116	0.000762	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PRSS1—pancreatitis	0.000116	0.000761	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ALB—pancreatitis	0.000114	0.000745	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADH4—pancreatitis	0.000114	0.000744	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PRSS1—pancreatitis	0.000113	0.000743	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—XDH—pancreatitis	0.000111	0.000725	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PNLIP—pancreatitis	0.00011	0.000721	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PRSS3—pancreatitis	0.00011	0.000721	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	0.000108	0.000707	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PRSS3—pancreatitis	0.000107	0.000704	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PNLIP—pancreatitis	0.000107	0.000704	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PRSS1—pancreatitis	0.000107	0.0007	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADH1B—pancreatitis	0.000103	0.000676	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PNLIP—pancreatitis	0.000101	0.000663	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PRSS3—pancreatitis	0.000101	0.000663	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGS2—pancreatitis	9.95e-05	0.000652	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—XDH—pancreatitis	9.88e-05	0.000647	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—LPL—pancreatitis	9.71e-05	0.000636	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—XDH—pancreatitis	9.64e-05	0.000632	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CTRB2—pancreatitis	9.22e-05	0.000604	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADH1B—pancreatitis	9.21e-05	0.000603	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—XDH—pancreatitis	9.09e-05	0.000595	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADH1B—pancreatitis	8.99e-05	0.000589	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—LPL—pancreatitis	8.67e-05	0.000568	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADH1B—pancreatitis	8.47e-05	0.000555	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	8.41e-05	0.000551	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PLA2G1B—pancreatitis	8.23e-05	0.000539	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—FDX1—pancreatitis	7.99e-05	0.000524	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—A2M—pancreatitis	7.95e-05	0.000521	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	7.85e-05	0.000515	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	7.79e-05	0.00051	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADH4—pancreatitis	7.43e-05	0.000487	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PLA2G1B—pancreatitis	7.35e-05	0.000481	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALDH2—pancreatitis	7.27e-05	0.000476	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PLA2G1B—pancreatitis	7.17e-05	0.00047	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—A2M—pancreatitis	7.1e-05	0.000465	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	7.09e-05	0.000464	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PRSS1—pancreatitis	6.99e-05	0.000458	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—A2M—pancreatitis	6.93e-05	0.000454	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PLA2G1B—pancreatitis	6.76e-05	0.000443	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PRSS3—pancreatitis	6.62e-05	0.000434	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PNLIP—pancreatitis	6.62e-05	0.000434	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—A2M—pancreatitis	6.53e-05	0.000428	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALDH2—pancreatitis	6.49e-05	0.000425	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALB—pancreatitis	6.37e-05	0.000418	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALDH2—pancreatitis	6.33e-05	0.000415	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	6.33e-05	0.000415	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALDH2—pancreatitis	5.97e-05	0.000391	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—XDH—pancreatitis	5.94e-05	0.000389	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALB—pancreatitis	5.69e-05	0.000373	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	5.58e-05	0.000365	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADH1B—pancreatitis	5.54e-05	0.000363	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GCG—pancreatitis	5.51e-05	0.000361	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	5.28e-05	0.000346	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	4.98e-05	0.000326	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GCG—pancreatitis	4.92e-05	0.000322	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GCG—pancreatitis	4.8e-05	0.000314	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GCG—pancreatitis	4.52e-05	0.000296	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLA2G1B—pancreatitis	4.42e-05	0.000289	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LPL—pancreatitis	4.32e-05	0.000283	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—A2M—pancreatitis	4.27e-05	0.00028	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDH2—pancreatitis	3.9e-05	0.000256	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LPL—pancreatitis	3.86e-05	0.000253	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LPL—pancreatitis	3.77e-05	0.000247	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LPL—pancreatitis	3.55e-05	0.000233	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARG—pancreatitis	3.16e-05	0.000207	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—INS—pancreatitis	3.1e-05	0.000203	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GCG—pancreatitis	2.96e-05	0.000194	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALB—pancreatitis	2.84e-05	0.000186	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARG—pancreatitis	2.82e-05	0.000185	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—INS—pancreatitis	2.76e-05	0.000181	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARG—pancreatitis	2.75e-05	0.00018	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—INS—pancreatitis	2.7e-05	0.000177	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARG—pancreatitis	2.59e-05	0.00017	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—INS—pancreatitis	2.54e-05	0.000167	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALB—pancreatitis	2.53e-05	0.000166	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—pancreatitis	2.48e-05	0.000163	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALB—pancreatitis	2.47e-05	0.000162	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALB—pancreatitis	2.33e-05	0.000153	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPL—pancreatitis	2.32e-05	0.000152	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—pancreatitis	2.22e-05	0.000145	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—pancreatitis	2.16e-05	0.000142	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—pancreatitis	2.04e-05	0.000134	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARG—pancreatitis	1.69e-05	0.000111	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—INS—pancreatitis	1.66e-05	0.000109	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALB—pancreatitis	1.52e-05	9.98e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—pancreatitis	1.33e-05	8.73e-05	CbGpPWpGaD
